Leslie Lauersdorf, ARNP
Moffitt Cancer Center
Tampa Bay, Florida
Tampa Bay, Florida
Authored Items
Conference Correspondent
Leslie Lauersdorf insist that it's vital to inform your patients about what's involved in beginning daratumumab treatments, especially because of the lengthy chair time. Read More ›
Conference Correspondent
Leslie Lauersdorf hopes that multiple myeloma can eventually become a chronic disease, if not cured completely, so that patients with the disease can live life uninterrupted. Read More ›
Conference Correspondent
Leslie Lauersdorf is excited by the prospect of new mutliple myeloma therapies, and notes that finding the best sequence for each patient is key. Read More ›
Conference Correspondent
Leslie Lauersdorf notes that having patients assist in managing their own side effects is important to help them stay on treatment and improve their quality of life. Read More ›
Conference Correspondent
Leslie Lauersdorf believes patient education is important in both newly diagnosed pateints with multiple myeloma or patients with relapsed/refractory disease to help them understand their disease and the different treatment options. Read More ›
Conference Correspondent
Leslie Lauersdorf discusses the need to balance optimism and realism in caring for patients with relapsed/refractory multiple myeloma. Read More ›
Conference Correspondent
Leslie Lauersdorf addresses the challenges associated with staying abreast of the side effects, management, and sequencing for new multiple myeloma treatments. Read More ›
Conference Correspondent
Leslie Lauersdorf discusses her perceptions regarding daratumumab therapy and identifies how her patients have benefited from this treatment option. Read More ›
Conference Correspondent
Leslie Lauersdorf addresses the different questions her patients ask her when they begin daratumumab therapy. Read More ›
Conference Correspondent
Leslie Lauersdorf explains why it's so important to understand the patient's baseline to help manage side effects. Read More ›
Conference Correspondent
Leslie Lauersdorf has seen the Janssen CarePath Program help alleviate some of the financial burden of treatment for her patients. Read More ›